Japanese pharma group declares win in billion-dollar royalties dispute
Japan’s Mitsubishi Tanabe Pharma Corporation says it has defeated an ICC claim brought by Switzerland’s Novartis over royalties for a treatment for multiple sclerosis – a dispute understood to be worth around US$3 billion.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.